Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Deciphering Antitumour Response and Resistance With INtratumour Heterogeneity - DARWINII

NCT02314481 is registered in ClinicalTrials.gov with University College, London as lead sponsor.

NCT NCT02314481
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02314481 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Deciphering Antitumour Response and Resistance With INtratumour Heterogeneity - DARWINII
Lead sponsor
University College, London
Phase
Phase 2
Overall status
Completed
Start date
May 12, 2017
Completion date
November 30, 2025
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

non-small cell lung cancer